Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2026-01-18 @ 6:33 PM
Study NCT ID:
NCT00226759
Status:
COMPLETED
Last Update Posted:
2012-10-12
First Post:
2005-09-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of OMS103HP in Patients Undergoing Allograft Anterior Cruciate Ligament (ACL) Reconstruction
Sponsor:
Omeros Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C03511
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None